Bristol-Myers Squibb

Major Weekend Biotech Announcements Could Produce Gains on Monday
Motley Fool
Mon, 12/10/12 - 10:39 am
Pharmacyclics
JNJ
ibrutinib
Eliquis
Pfizer
Bristol-Myers Squibb
Looking For A Long-Term Pharma Play?
Seeking Alpha
Sun, 12/9/12 - 11:31 am
Roche
Astrazena
Bristol-Myers Squibb
GSK
Blood Thinner From Pfizer, Bristol-Myers Blocks Leg Clots
Bloomberg
Sun, 12/9/12 - 11:22 am
Bristol-Myers Squibb
Pfizer
Eliquis
blood thinners
anticoagulants
This Blockbuster Drug Gets a Green Light
Motley Fool
Sat, 12/8/12 - 11:31 am
Bristol-Myers Squibb
arthritis
Orencia
OncoSec Medical: 2013 Will Be A Year Of Crucial Events
Seeking Alpha
Thu, 12/6/12 - 05:33 pm
OncoSec Medical
Amgen
Dendreon
Vical
Bristol-Myers Squibb
1 Event That Could Make or Break Biotech Stocks
Motley Fool
Thu, 12/6/12 - 10:50 am
Halozyme
Isis Pharmaceuticals
Biomarin
Bristol-Myers Squibb
Sarepta
Why Bristol-Myers Is Worth a Look
Motley Fool
Wed, 11/28/12 - 10:36 am
Bristol-Myers Squibb
5 Drug Hopefuls That Are Going to Change Your Life: Part 2
Motley Fool
Sat, 11/24/12 - 12:01 pm
Gilead Sciences
sofosbuvir
hepatitis C
Bristol-Myers Squibb
BMS-986094
Idenix
IDX-184
Abbott Laboratories
Achillion
ACH-3102
Armed with EU stroke approval, Pfizer, BMS talk up Eliquis' edge over rivals
Fierce Pharma
Wed, 11/21/12 - 12:28 pm
Europe
stroke
Pfizer
Eliquis
bloodthinners
Bristol-Myers Squibb
Revisiting Buyout Rumors After Teva's CEO Shifts Focus To 'Smaller Acquisitions'
Seeking Alpha
Wed, 11/21/12 - 11:15 am
Teva
M&A
Bristol-Myers Squibb
Eli Lilly
Novartis
Prolor
Pfizer
Novo Nordisk A/S: Catching The Increasing Diabetes Trend
Seeking Alpha
Tue, 11/20/12 - 11:27 am
diabetes
Novo Nordisk
Bristol-Myers Squibb
Eli Lilly
Sanofi
Biocon, Bristol-Myers in deal for oral insulin drug
Reuters
Fri, 11/16/12 - 10:10 am
Biocon
Bristol-Myers Squibb
insulin
diabetes
IN-105
Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thu, 11/15/12 - 10:47 am
Teva
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Merck
Novo Nordisk
Novartis
Pfizer
Sanofi
Bristol-Myers, AstraZeneca Type 2 diabetes pill gets first major approval, in European Union
Yahoo/AP
Thu, 11/15/12 - 10:46 am
diabetes
Bristol-Myers Squibb
AstraZeneca
Europe
SGLT2 inhibitor
Forxiga
Who Will Pioneer the New Diabetes Market?
Motley Fool
Thu, 11/15/12 - 10:45 am
diabetes
JNJ
Merck
Bristol-Myers Squibb
AstraZeneca
SGLT2 inhibitor
Bristol-Myers Hepatitis C Combo Therapy Shows Promise
Bloomberg
Tue, 11/13/12 - 11:11 am
hepatitis C
Bristol-Myers Squibb
BMS-791325
asunaprevir
declatasvir
CVS shucking more drugs from its coverage list
Fierce Pharma
Fri, 11/9/12 - 11:26 am
CVS
pharmacy benefits
Allergan
Lumigan
Androgel
Abbott Labs
Pfizer
Genotropin
Bristol-Myers Squibb
AstraZeneca
Onglyza
Bristol-Myers, Chiromics form drug discovery strategic alliance
Yahoo/Fly the on Wall
Fri, 11/9/12 - 09:56 am
Chiromics
drug discovery
Bristol-Myers Squibb
Vical's Allovectin: Update On The Phase III Trial
Seeking Alpha
Thu, 11/8/12 - 10:50 am
Vical
Allovectin
Bristol-Myers Squibb
JNJ
melanoma
5 Companies Dominating Diabetes
Motley Fool
Tue, 11/6/12 - 04:21 pm
diabetes
AstraZeneca
Bristol-Myers Squibb
Sanofi
Novo Nordisk
MannKind

Pages